Showing results (141-150 of 301) with videos related to

Sort By:
Pageof 31
Indian Journal of Pediatrics|January 21, 2011
COL1A1 mutation in an Indian child with Caffey diseasePrajnya Ranganath, Christine M Laine, Divya Gupta, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 22, 2016
The receptor for advanced glycation end products impairs collateral formation in both diabetic and non-diabetic miceLaura M Hansen, Divya Gupta, Giji Joseph, et al.
International Journal of Dermatology|July 2, 2014
Type 1 lepra reaction in histoid leprosyNidhi Singh, Rashmi Kumari, Divya Gupta, et al.
Developmental Biology|May 24, 2011
Conditional disruption of mouse Klf5 results in defective eyelids with malformed meibomian glands, abnormal cornea and loss of conjunctival goblet cellsDoreswamy Kenchegowda, Sudha Swamynathan, Divya Gupta, et al.
Current Genomics|March 14, 2022
In Silico Analysis of CCGAC and CATGTG Cis-regulatory Elements Across Genomes Reveals their Roles in Gene Regulation under StressSneha Lata Bhadouriya, Abhishek Suresh, Himanshu Gupta, et al.
The Journal of General Virology|December 11, 2019
mTORC1 restricts hepatitis C virus RNA replication through ULK1-mediated suppression of miR-122 and facilitates post-replication eventsManish Kumar Johri, Hiren Vasantrai Lashkari, Divya Gupta, et al.
Experimental Eye Research|October 1, 2013
Regulation of mouse lens maturation and gene expression by Krüppel-like factor 4Divya Gupta, Stephen A K Harvey, Doreswamy Kenchegowda, et al.
ACS Infectious Diseases|February 27, 2024
Synergistic Binding of SARS-CoV-2 to ACE2 and Gangliosides in Native Lipid MembranesManorama Dey, Anurag Sharma, Garvita Dhanawat, et al.
Practical Radiation Oncology|June 9, 2023
Partial-Length Treatment With Brachytherapy in Patients With Endometrial Cancer With High-Risk Features Is as Effective as Full-Length Vaginal Brachytherapy but With Reduced ToxicityA Gabriella Wernicke, Bhupesh Parashar, Eileen Samuel, et al.
Oncology and Therapy|April 4, 2023
Real-World Outcomes Following First-Line Treatment in Patients with Advanced Ovarian Cancer with Multiple Risk Factors for Disease Progression who Received Maintenance Therapy or Active SurveillanceDana Chase, Jessica Perhanidis, Divya Gupta, et al.
Pageof 31